SPIA
AMPH icon

Steward Partners Investment Advisory’s Amphastar Pharmaceuticals AMPH Stock Holding History

Steward Partners Investment Advisory’s Portfolio AMPH Stock Details AMPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.02K Hold
100
– – ﹤0.01% 4233
2026
Q1 		$1.96K Buy
+100
New +$2.45K ﹤0.01% 4061
2024
Q4 		– Sell
-400
Closed -$19.4K – 3974
2024
Q3 		$19.4K Sell
400
-250
-38% -$11K ﹤0.01% 2671
2024
Q2 		$26K Buy
650
+400
+160% +$16.6K ﹤0.01% 2409
2024
Q1 		$11K Hold
250
– – ﹤0.01% 2774
2023
Q4 		$15.5K Hold
250
– – ﹤0.01% 2521
2023
Q3 		$11.5K Buy
+250
New +$13.6K ﹤0.01% 2540
2020
Q1 		– Sell
-1
Closed – – 2479
2019
Q4 		$0 Hold
1
– – ﹤0.01% 2581
2019
Q3 		$0 Hold
1
– – ﹤0.01% 2607
2019
Q2 		$0 Buy
+1
New +$21 ﹤0.01% 2603

Other funds holding AMPH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Steward Partners Investment Advisory's AMPH Position: Q2 2026 in Review

Steward Partners Investment Advisory held its Amphastar Pharmaceuticals (AMPH) position steady in Q2 2026 at 100 shares worth $2.02K. The position accounts for ﹤0.01% of the portfolio, ranked #4233.

Steward Partners Investment Advisory first reported a position in AMPH in Q2 2019 and has held it in 10 quarters since. The position peaked at $26K in Q2 2024. 211 funds tracked by Wall St. Rank hold AMPH as of Q2 2026.

  • Steward Partners Investment Advisory held 100 shares of Amphastar Pharmaceuticals worth $2.02K as of Q2 2026.
  • Steward Partners Investment Advisory left its Amphastar Pharmaceuticals share count unchanged in Q2 2026.
  • Amphastar Pharmaceuticals made up ﹤0.01% of Steward Partners Investment Advisory's portfolio in Q2 2026, its #4233 holding.
  • Steward Partners Investment Advisory first reported a position in Amphastar Pharmaceuticals in Q2 2019 and has held it in 10 quarters since.
  • Steward Partners Investment Advisory's Amphastar Pharmaceuticals position peaked at $26K in Q2 2024.
  • 211 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q2 2026.

Based on Steward Partners Investment Advisory's 13F filing for Q2 2026, filed 13 Aug 2026.